Background Insufficient data are available from single cohort studies to allow estimation of
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …

Background Combination antiretroviral therapy (ART) has significantly increased survival
among HIV-positive adults in the United States (US) and Canada, but gains in life expectancy …

Background The optimal time for the initiation of antiretroviral therapy for asymptomatic patients
with human immunodeficiency virus (HIV) infection is uncertain. Methods We conducted …

Context.—Clinical trials have established the efficacy of antiretroviral therapy with double-
and triple-drug regimens for individuals infected with the human immunodeficiency virus (HIV)…

ContextCurrent recommendations for initiation of antiretroviral therapy in patients infected
with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts …

Background Results of cohort studies and mathematical models have suggested that
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …

Objective To establish the reliability and validity of a shortened (10-item) depression scale
used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia…

Context.—In British Columbia, human immunodeficiency virus (HIV)–infected persons eligible
for antiretroviral therapy may receive it free but the extent to which HIV-infected injection …

Objective. The objective of this study was to systematically characterize the incidence and
determinants of antiretroviral resistance in the HOMER (Highly Active Antiretroviral Therapy […

Results As of 30 September 2000, 106 subjects had died. Cumulative mortality was 3.9%(±0.5%)
at 12 months. In a multivariate model, after controlling for other variables that were …